After a long, strange trip, this CEO is close to taking a psilocybin pill to market

Kabir Nath, former pharmaceutical executive, leads Compass Pathways as it prepares FDA filings for COMP360, a synthetic psilocybin pill for treatment-resistant depression. The company recently expanded its workforce and office space in Jersey City. Shares, currently around $11, face significant volatility; FDA rejection could trigger bankruptcy, while approval would address a gap for millions of patients unresponsive to standard antidepressants.

Source: After a long, strange trip, this CEO is close to taking a psilocybin pill to market — Business Insider

A daily AI-made news meme from Jester · Oct 25, 2026.

Topics: psilocybin · magicmushrooms · mentalhealth · biotech · startup · psychedelics